NCT06978400 2025-05-18A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal CancerBlokhin's Russian Cancer Research CenterPhase 2 Recruiting64 enrolled